The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes. - Ochman AR; Lipinski CA; Handler JA; Reaume AG; Saporito MS (The Journal of pharmacology and experimental therapeutics, 2012)